Market Tracker

10/24 6:05pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.72
Data as of Oct 24
 +0.11 / +2.39%
Today’s Change
3.10
Today|||52-Week Range
7.45
-11.44%
Year-to-Date

Today’s Trading

Previous close4.61
Today’s open4.62
Day’s range4.50 - 4.73
Volume763,999
Average volume (3 months)898,651
Market cap$320.7M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+97.37%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
TKAITokai Pharmaceutical...-0.01-0.07%
SUPNSupernus Pharmaceuti...+0.02+0.27%
SNTASynta Pharmaceutical...+0.00+0.17%
XNCRXencor Inc0.000.00%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts